420 with CNW – Marijuana Investor Donates Millions to Harvard and MIT for Cannabis Research

Charles R. Broderick, a cannabis investor, has donated $9 million to his alma mater (Harvard and Massachusetts Institute of Technology-MIT) so that the two institutions can conduct research into the health effects of cannabis.

The two academic institutions described the donation that they had received as the largest ever private funding into marijuana research.

Speaking about his donation, Broderick said that the absence of sufficient scientific research on cannabis has allowed some players in the industry to make claims that may be hard to verify. He added that since prohibitionist laws are collapsing around the world, the time has come to study the plant so that people have accurate information rather than having to rely on old science or anecdotal evidence.

One of the areas that will be focused on during the research funded by Broderick is the psychological and cognitive effects of marijuana.

Charles R. Broderick has been investing in the cannabis industry since 2015. He got his feet wet in Canada and then later expanded his interests into the U.S. marijuana industry.

The investor reveals that Harvard was initially reluctant to accept his donation due to Broderick’s involvement in the cannabis industry. However, his offer was accepted after brain chemical researchers at the university were excited by the opportunity.

MIT and Harvard insist that the findings of the research will not be influenced in any way by the interests of the donor. The institutions vowed that they would release their findings to the public regardless of whether the findings indicate that marijuana is harmful or helpful.

Meanwhile, interest in cannabis research is growing in academic circles. Additionally, the boom in marijuana industry jobs has prompted many universities to start offering some form of cannabis courses.

For example, Colorado State University offers students a minor in the legal, social, health and political impact of cannabis. Harvard, Ohio State University and the University of Denver all offer courses on marijuana law and policy.

The jobs that students expect to get after taking those cannabis courses vary in accordance with the range of products and services created by the cannabis industry. These include the medical uses of cannabis, the manufacture of fabrics from hemp, the processing of cannabis-infused foods and beverages, making of recreational cannabis products, etc.

Currently, recreational marijuana is legal in 10 states and more are queuing to join that list. Medical cannabis is permitted in 33 states across the U.S. For this reason, MustGrow Biologics Corp. and Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) welcome the donation made by Broderick since the research done will make more information available about cannabis so that the excuse of insufficient research used by detractors will be no more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Leave a Reply